Glucose-Regulated Protein of 94kDa (Grp94)-Targeted Antibody-Based Combinatorial Immunotherapy for Intrahepatic Cholangiocarcinoma
Year: 2016
Type: article
Institution: Massachusetts General Hospital
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2531630355
